Novabay Pharmaceuticals (NBY) EGM 2024 summary

Opening remarks and agenda

• Meeting called to order at 11:00 A.M. Pacific Time, with introductions of board members and key guests.

• Purpose was to continue the special meeting adjourned from November 22nd to solicit more votes on two key proposals.

Specific resolutions to be voted on

• Proposal One: Approval of the sale of Avenova, representing substantially all company assets, to PRN Physician Recommended Nutraceuticals.

• Proposal Two: Approval of the liquidation and dissolution of the company, subject to board discretion.

Corporate governance

• Notice of the reconvened meeting and proxy materials were properly distributed to all stockholders of record.

• Inspector of election and outside counsel were present to ensure procedural compliance.